Edgar Filing: NORTHFIELD LABORATORIES INC /DE/

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â BALYASNY ASSET MANAGEMENT LLC

2. Date of Event Requiring Statement (Month/Day/Year)
12/08/2006

3. Issuer Name and Ticker or Trading Symbol
NORTHFIELD LABORATORIES INC /DE/ [NFLD]

(Last)

(First)

(Middle)

135 E. 57TH STREET,Â 27TH FL

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

NEW YORK,Â NYÂ 10022

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,439	I	See Footnotes ⁽¹⁾ ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	12/08/2006	01/20/2007	Common Stock	11,000	$ 5	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	01/20/2007	Common Stock	316,400	$ 25	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	01/20/2007	Common Stock	392,200	$ 7.5	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	01/20/2007	Common Stock	1,124,400	$ 22.5	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	01/20/2007	Common Stock	500	$ 17.5	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	12/16/2006	Common Stock	181,000	$ 20	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	12/16/2006	Common Stock	50,000	$ 25	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	12/16/2006	Common Stock	50,000	$ 30	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	12/16/2006	Common Stock	72,000	$ 7.5	I	See Footnotes ⁽¹⁾ ⁽²⁾
Stock Option	12/08/2006	12/16/2006	Common Stock	480,700	$ 22.5	I	See Footnotes ⁽¹⁾ ⁽²⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
BALYASNY ASSET MANAGEMENT LLC 135 E. 57TH STREET 27TH FL NEW YORK,Â NYÂ 10022	Â	Â X	Â	Â
Balyasny Dmitry 181 W. MADISON STREET; SUITE 3600 CHICAGO,Â ILÂ 60602	Â	Â X	Â	Â

Signatures

/S/ SCOTT SCHROEDER, AUTHORIZED SIGNATORY FOR BALYASNY ASSET MANAGEMENT L.P.		12/13/2006
^**Signature of Reporting Person		Date
/S/ SCOTT SCHROEDER, AUTHORIZED SIGNATORY FOR DMITRY BALYASNY		12/13/2006
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These shares are held as follows: Atlas Master Fund, Ltd. ("AMF") owns 5.86% or 157,788 shares; Visium Balanced Fund, LP ("VBF") owns 21.92% or 590,226 shares; Visium Long Bias Fund, LP ("VLB") owns 9.41% or 253,377 shares; Visium Balanced Offshore Fund, Ltd. ("VBOF") owns 36.34% or 978,505 shares; and Visium Long Bias Offshore Fund Ltd. ("VLBOF") owns 25.85% or 696,047 shares. Additionally, Dmitry Balyasny owns 0.63% or 16,695 shares. By virtue of its position as investment advisor and/or sub-advisor to each of Atlas Master Fund, Ltd. ("AMF"), Atlas Global, LLC ("AG"), Atlas Global Investments, Ltd. ("AGI"), Atlas Global Investments II, Ltd. ("AGII"), Visium Balanced Fund LP ("VBF"), Visium Long Bias Fund LP ("VLB"), Visium Balanced Offshore Fund, Ltd. ("VBOF") and Visium Long Bias Offshore Fund Ltd. ("VLBOF"), Balyasny Asset Management L.P. may be deemed to beneficially own all 2,692,639 shares of Common Stock.
(2)	By virtue of Atlas Global, LLC's ("AG") ownership of 10.79% of the equity interest in AMF, AG may be deemed to beneficially own the 157,788 shares of Northfield Laboratories, Inc.'s ("NFLD") stock that is beneficially owned by AMF. By virtue of Atlas Global Investments, Ltd. ("AGI") ownership of 83.72% of the equity interest in AMF, AGI may be deemed to beneficially own the 157,788 shares of NFLD stock that is beneficially owned by AMF. By virtue of Atlas Global Investments II, Ltd. ("AGII") ownership of 5.48% of the equity interest in AMF, AGII may be deemed to beneficially own the 157,788 shares of OTCI stock that is beneficially owned by AMF.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.